MGMT and colorectal cancer: Thus, in a large study of germline genotypes (WBC) including a validation cohort, Kuroiwa-Trzmielina and colleagues found the rs16906252 alternative T-allele to be associated with an odds ratio (OR) of 3–4 for developing MGMT promoter–methylated colorectal cancer.